Pattaranutaporn, P <br/><br/>
Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma.  [electronic resource] 

 -  Gynecologic oncology  Jun 2001 
 - 404-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1006/gyno.2001.6197  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--adverse effects<br/>Brachytherapy<br/>Carcinoma, Squamous Cell--drug therapy<br/>Combined Modality Therapy<br/>Deoxycytidine--adverse effects<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Staging<br/>Radiation-Sensitizing Agents--adverse effects<br/>Radiotherapy--adverse effects<br/>Uterine Cervical Neoplasms--drug therapy<br/>Gemcitabine